Page last updated: 2024-12-11

arglabin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

arglabin: a sesquiterpene lactone from the Chinese herb Artemisia myriantha; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

arglabin : An organic heterotetracyclic compound and guaianolide sesquiterpene lactone that is acrylic acid which is substituted at position 2 by a 4-hydroxy-3,8-dimethyl-1,3a,4,5,6,7-hexahydroazulen-5-yl group in which the double bond in the 7-membered ring has been epoxidised and in which the hydroxy group and the carboxy group have undergone formal condensation to give the corresponding gamma-lactone. It is found in Artemisia glabella. Arglabin-DMA HCl, the hydrochloride salt of the adduct resulting from the conjugate addition of dimethylamine to the ene-lactone moiety, has been successfully used in Khazakhstan for the treatment of breast, colon, ovarian and lung cancers. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
ArtemisiagenusA plant genus of the family ASTERACEAE with strong-smelling foliage. It is a source of SANTONIN and other cytotoxic TERPENES.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID5574924
CHEMBL ID2206431
CHEBI ID73228
SCHEMBL ID60010
MeSH IDM0221778

Synonyms (25)

Synonym
arglabin
84692-91-1
3h-oxireno(8,8a)azuleno(4,5-b)furan-8(4ah)-one, 5,6,6a,7,9a,9b-hexahydro-1,4a-dimethyl-7-methylene-
ys8uop7qz1 ,
unii-ys8uop7qz1
(+)-arglabin
arglabin=dma
CHEMBL2206431
CHEBI:73228 ,
1beta,10beta-epoxyguaia-3,11(13)-dien-12,6alpha-olide
(3ar,4as,6as,9as,9br)-1,4a-dimethyl-7-methylene-5,6,6a,7,9a,9b-hexahydro-3h-oxireno[8,8a]azuleno[4,5-b]furan-8(4ah)-one
bdbm50433455
HY-16059
SCHEMBL60010
AKOS030485961
(1r,3s,6s,10s,11r)-3,12-dimethyl-7-methylidene-2,9-dioxatetracyclo[9.3.0.01,3.06,10]tetradec-12-en-8-one
Q24522351
3h-oxireno(8,8a)azuleno(4,5-b)furan-8(4ah)-one, 5,6,6a,7,9a,9b-hexahydro-1,4a-dimethyl-7-methylene-, (4as-(3as*,4a.alpha.,6a.alpha.,9a.beta.,9b.alpha.))-
3h-oxireno(8,8a)azuleno(4,5-b)furan-8(4ah)-one, 5,6,6a,7,9a,9b-hexahydro-1,4a-dimethyl-7-methylene-, (3ar,4as,6as,9as,9br)-
arglabine
BCP09930
MS-23492
(+)-arglabin(+)-arglabin
(1r,3s,6s,10s,11s)-3,12-dimethyl-7-methylidene-2,9-dioxatetracyclo[9.3.0.01,3.06,10]tetradec-12-en-8-one
(1r,3s,6s,10s,11r)-3,12-dimethyl-7-methylidene-2,9-dioxatetracyclo[9.3.0.0?,?.0?,??]tetradec-12-en-8-one

Research Excerpts

Overview

Arglabin is a derivative of parthenolide. Arglabin-DMA is a registered antitumor substance in the Republic of Kazakstan.

ExcerptReferenceRelevance
"Arglabin (Arg) is a derivative of parthenolide. "( Arglabin regulates microglia polarization to relieve neuroinflammation in Alzheimer's disease.
Guo, L; Han, C; Li, W; Wang, J; Yang, Y; Zhang, C; Zhou, X, 2022
)
3.61
"Arglabin-DMA is a registered antitumor substance in the Republic of Kazakstan."( Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase.
Adekenov, SM; Baker, FL; Madden, TL; Newman, R; Prashad, N; Shaikenov, TE; Williams, RM,
)
2.3

Effects

ExcerptReferenceRelevance
"Arglabin has very low toxicity and eliminates the toxic effects of standard chemotherapy."( NEOADJUVANT СHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER.
Amanov, A; Fomenko, Y; Kabildina, N; Omarova, I; Sirota, V, 2017
)
1.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
organic heterotetracyclic compound
gamma-lactoneA lactone having a five-membered lactone ring.
epoxideAny cyclic ether in which the oxygen atom forms part of a 3-membered ring.
sesquiterpene lactoneAny member of a diverse class of complex, multicyclic phytochemicals showing a variety of skeleton arrangements and bioactivities, and having in common a sesquiterpenoid structure including a lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
PPM1D proteinHomo sapiens (human)Potency16.53880.00529.466132.9993AID1347411
Interferon betaHomo sapiens (human)Potency16.53880.00339.158239.8107AID1347411
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transcriptional activator MybGallus gallus (chicken)IC50 (µMol)17.41910.62522.76989.5499AID746038
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (32)

Processvia Protein(s)Taxonomy
regulation of gene expressionTranscriptional activator MybGallus gallus (chicken)
mitotic cell cycleTranscriptional activator MybGallus gallus (chicken)
positive regulation of transcription by RNA polymerase IITranscriptional activator MybGallus gallus (chicken)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
protein bindingTranscriptional activator MybGallus gallus (chicken)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscriptional activator MybGallus gallus (chicken)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscriptional activator MybGallus gallus (chicken)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleoplasmTranscriptional activator MybGallus gallus (chicken)
nucleusTranscriptional activator MybGallus gallus (chicken)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1347412qHTS assay to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: Counter screen cell viability and HiBit confirmation2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID746037Cytotoxicity against chicken HD11 cells assessed as cell viability after 24 hrs by MTS assay2013European journal of medicinal chemistry, May, Volume: 63Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
AID746038Inhibition of c-Myb-induced mim-1 gene expression in doxycyclin-treated chicken HD11 cells after 24 hrs by GFP assay2013European journal of medicinal chemistry, May, Volume: 63Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
AID1469798Cytotoxicity against human A431 cells assessed as reduction in cell viability after 96 hrs by SRB asssay2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID713355Cytotoxicity against human leukemia stem/progenitor cells assessed as viable CD34+ cells at 10 uM after 18 hrs by annexin-V labeling-based flow cytometry relative to control2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID713361Cytotoxicity against human leukemia stem/progenitor cells assessed as cell viability at 10 uM after 18 hrs by annexin-V labeling-based flow cytometry2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID1469800Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by SRB asssay2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID1469797Cytotoxicity against human 518A2 cells assessed as reduction in cell viability after 96 hrs by SRB asssay2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID1469801Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by SRB asssay2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID713354Cytotoxicity against human leukemia stem/progenitor cells assessed as viable CD34+CD38- cells at 10 uM after 18 hrs by annexin-V labeling-based flow cytometry relative to control2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID1469799Cytotoxicity against human A549 cells assessed as reduction in cell viability after 96 hrs by SRB asssay2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID713359Cytotoxicity against human leukemia stem/progenitor cells assessed as viable CD34+ cells at 10 uM after 18 hrs by annexin-V labeling-based flow cytometry2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.00)18.2507
2000's3 (12.00)29.6817
2010's14 (56.00)24.3611
2020's7 (28.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.67 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index5.47 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (10.71%)5.53%
Reviews5 (17.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]